Search Results - "DECKERT, P. M" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Diagnostic Performance of Contrast Enhanced Pulmonary Computed Tomography Angiography for the Detection of Angioinvasive Pulmonary Aspergillosis in Immunocompromised Patients

Diagnostic Performance of Contrast Enhanced Pulmonary Computed Tomography Angiography for the Detection of Angioinvasive Pulmonary Aspergillosis in Immunocompromised Patients

by Henzler, C., Henzler, T., Buchheidt, D., Nance, John W., Weis, C. A., Vogelmann, R., Benck, U., Viergutz, T., Becher, T., Boch, T., Klein, S. A., Heidenreich, D., Pilz, L., Meyer, M., Deckert, P. M., Hofmann, W.-K., Schoenberg, S. O., Reinwald, M.
Published in Scientific reports (30.06.2017)

Get full text

Journal Article

A33scFv-cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy

A33scFv-cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy

by DECKERT, P. M, RENNER, C, COHEN, L. S, JUNGBLUTH, A, RITTER, G, BERTINO, J. R, OLD, L. J, WELT, S
Published in British journal of cancer (24.03.2003)

Get full text

Journal Article

Current constructs and targets in clinical development for antibody-based cancer therapy

Current constructs and targets in clinical development for antibody-based cancer therapy

by Deckert, P M
Published in Current drug targets (01.02.2009)

Get more information

Journal Article

Targeted enzyme prodrug therapies

Targeted enzyme prodrug therapies

by Schellmann, N, Deckert, P M, Bachran, D, Fuchs, H, Bachran, C
Published in Mini reviews in medicinal chemistry (01.09.2010)

Get more information

Journal Article

Phase I/II trial of topotecan given as continuous infusion in combination with oxaliplatin in 5-FU-pretreated patients with colorectal cancer

Phase I/II trial of topotecan given as continuous infusion in combination with oxaliplatin in 5-FU-pretreated patients with colorectal cancer

by HÜTTER, G, SZELENYI, H, DECKERT, P. M, KEILHOLZ, U, THIEL, E
Published in Cancer chemotherapy and pharmacology (01.08.2004)

Get full text

Journal Article

1079PDose adjustment of chemotherapy in aggressive lymphoma using automated and standardized analysis and evaluation of DNA double strand breaks

1079PDose adjustment of chemotherapy in aggressive lymphoma using automated and standardized analysis and evaluation of DNA double strand breaks

by Schröder, J, Rödiger, S, Ruhe, M, Deckert, P M
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

Pharmacokinetics and microdistribution of polyethylene glycol‐modified humanized A33 antibody targeting colon cancer xenografts

Pharmacokinetics and microdistribution of polyethylene glycol‐modified humanized A33 antibody targeting colon cancer xenografts

by Deckert, P. Markus, Jungbluth, Achim, Montalto, Nicholas, Clark, Mike A., Finn, Ronald D., Williams Jr, Clarence, Richards, Elizabeth C., Panageas, Katherine S., Old, Lloyd J., Welt, Sydney
Published in International journal of cancer (01.08.2000)

Get full text

Journal Article Conference Proceeding

Specific tumour localisation of a huA33 antibody--carboxypeptidase A conjugate and activation of methotrexate-phenylalanine

Specific tumour localisation of a huA33 antibody--carboxypeptidase A conjugate and activation of methotrexate-phenylalanine

by Deckert, P Markus, Bornmann, William G, Ritter, Gerd, Williams, Jr, Clarence, Franke, Juergen, Keilholz, Ulrich, Thiel, Eckhard, Old, Lloyd J, Bertino, Joseph R, Welt, Sydney
Published in International journal of oncology (01.05.2004)

Get more information

Journal Article

CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination

CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination

by Deckert, PM, Ballmaier, M, Lang, S, Deicher, H, Schedel, I
Published in The Journal of immunology (1950) (15.01.1996)

Get full text

Journal Article

Targeted tumor therapy with a fusion protein of an antiangiogenic human recombinant scFv and yeast cytosine deaminase

Targeted tumor therapy with a fusion protein of an antiangiogenic human recombinant scFv and yeast cytosine deaminase

by Schellmann, Nicole, Panjideh, Hossein, Fasold, Patricia, Bachran, Diana, Bachran, Christopher, Deckert, Peter M, Fuchs, Hendrik
Published in Journal of immunotherapy (1997) (01.09.2012)

Get more information

Journal Article

Design, construction, and in vitro analysis of A33scFV: :CDy, a recombinant fusion protein for antibody-directed enzyme prodrug therapy in colon cancer

Design, construction, and in vitro analysis of A33scFV: :CDy, a recombinant fusion protein for antibody-directed enzyme prodrug therapy in colon cancer

by COELHO, Vania, DERNEDDE, Jens, PETRAUSCH, Ulf, PANJIDEH, Hossein, FUCHS, Hendrik, MENZEL, Christoph, DÜBEL, Stefan, KEILHOLZ, Ulrich, THIEL, Eckhard, DECKERT, P. Markus
Published in International journal of oncology (01.10.2007)

Get full text

Journal Article

Biodistribution and efficacy of [131I]A33scFv::CDy, a recombinant antibody-enzyme protein for colon cancer

Biodistribution and efficacy of [131I]A33scFv::CDy, a recombinant antibody-enzyme protein for colon cancer

by PANJIDEH, Hossein, DA SILVA COELHO, Vania Casimiro, DERNEDDE, Jens, BACHRAN, Christopher, FORSTER, Gregor J, FRANKE, Jürgen, FASOLD, Patricia, FUCHS, Hendrik, THIEL, Eckhard, DECKERT, P. Markus
Published in International journal of oncology (01.04.2008)

Get full text

Journal Article

A33scFv–Green fluorescent protein, a recombinant single-chain fusion protein for tumor targeting

A33scFv–Green fluorescent protein, a recombinant single-chain fusion protein for tumor targeting

by Petrausch, Ulf, Dernedde, Jens, Coelho, Vânia, Panjideh, Hossein, Frey, Dietmar, Fuchs, Hendrik, Thiel, Eckhard, Deckert, P. Markus
Published in Protein engineering, design and selection (01.12.2007)

Get full text

Journal Article

Phase II study of liposomal daunorubicin and ifosfamide (IDx) as first line chemotherapy in soft tissue sarcoma

Phase II study of liposomal daunorubicin and ifosfamide (IDx) as first line chemotherapy in soft tissue sarcoma

by Deckert, P. M., Siehl, J. M., Thiel, E., Schmittel, A., Hütter, G., Szelényi, H., Keilholz, U.
Published in Journal of clinical oncology (15.07.2004)

Get full text

Journal Article

Phase II study of liposomal daunorubicin and ifosfamide (IDx) as first line chemotherapy in soft tissue sarcoma

Phase II study of liposomal daunorubicin and ifosfamide (IDx) as first line chemotherapy in soft tissue sarcoma

by Deckert, P. M., Siehl, J. M., Thiel, E., Schmittel, A., Hütter, G., Szelényi, H., Keilholz, U.
Published in Journal of clinical oncology (15.07.2004)

Get full text

Journal Article

Short communication: A33scFv-cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy

Short communication: A33scFv-cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy

by Deckert, P M, Renner, C, Cohen, L S, Jungbluth, A, Ritter, G, Bertino, J R, Old, L J, Welt, S
Published in British journal of cancer (24.03.2003)

Get full text

Journal Article

Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma : Results of a phase II study

Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma : Results of a phase II study

by SIEHL, Jan M, THIEL, Eckhard, SCHMITTEL, Alexander, HIITTER, Gero, DECKERT, Peter M, SZELENYI, Hubert, KEILHOLZ, Ulrich
Published in Cancer (01.08.2005)

Get full text

Journal Article